| Financial Year |
March 31 2023 |
| Monetary Funds |
489,511,642.57 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
10,579,347.75 |
| Accounts Receivable |
1,032,819,180.23 |
| Advances to Suppliers |
54,014,728.02 |
| Other Receivables |
89,539,855.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
600,693,634.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
102,219,961.63 |
| Total Current Assets |
2,560,052,374.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
291,690,627.40 |
| Investment Properties |
-- |
| Fixed Assetes |
1,874,549,839.67 |
| Under-construction Projects |
1,599,670,447.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
270,614,526.82 |
| R&D expenses |
-- |
| Goodwill |
575,500,804.45 |
| Long-Term Deferred and Prepaid Expenses |
3,089,578.56 |
| Deferred Income Tax Assets |
45,374,081.47 |
| Other Non-Current Assets |
1,038,199,225.22 |
| Sub-Total of Non-Current Assets |
5,708,809,801.84 |
| Total Assets |
8,268,862,176.04 |
| Short-Term Loans |
1,589,719,215.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
307,808,158.13 |
| Accounts Payable |
345,384,095.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,703,883.51 |
| Taxes Payable |
19,899,659.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
45,633,959.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
569,336,380.36 |
| Other Current Liabilities |
7,747,836.19 |
| Sub-Total of Current Liabilities |
2,977,993,096.24 |
| Long-term Loans |
1,660,130,237.96 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
32,816,125.45 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,441,160.85 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
147,527,114.40 |
| Sub-Total of Non-Current Liabilities |
1,854,996,137.27 |
| Total Liabilities |
4,832,989,233.51 |
| Paid-In Capital(Or Share Stock) |
791,876,334.00 |
| Capital Surplus |
1,419,836,787.95 |
| Surplus Reserve |
161,555,913.66 |
| LESS:Treasury Stock |
184,408,893.00 |
| Undistributed Profits |
1,247,012,799.92 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,435,872,942.53 |
| Owner's Equity（Stockholder's Equity） |
3,435,872,942.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,268,862,176.04 |
